Injury & Recovery
Body-area terms help discovery; evidence remains tied to the actual population, route and endpoint studied.
How to read this page
Topic and body-area searches help discovery. They do not imply that evidence from one population, route or body site transfers to another.
Relevant compounds
Search all →
BPC-157BPC-157
Primarily preclinical / extremely limited human evidence across injury and GI claims
TB-500TB-500
Direct preclinical evidence with confirmed human drug-exposure gap
BPC-157 + T…BPC-157 + TB-500 blend
Blend — direct preclinical combination evidence; no human combination evidence
GHK-CuGHK-Cu
Topical/cosmetic human evidence is limited and mixed; injectable evidence limited
GHK-Cu + BP…GHK-Cu + BPC-157 + TB-500 blend
Blend — research complete evidence gap; no direct clinical blend evidence
KPVKPV
Preclinical / human-cell mechanistic; no established human drug exposure
Long R3 IGF…Long R3 IGF-1
Preclinical/biochemical evidence with human therapeutic-efficacy gap
Melanotan IIMelanotan II
Small direct human pharmacology signals; unapproved with major safety uncertainty
Acetyl octa…Acetyl octapeptide-3
Small human cosmetic formulation-level evidence; isolated ingredient effect not esta…
CerebrolysinCerebrolysin
Human clinical evidence — indication-dependent / regionally marketed